• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mTORC1 的抑制作用以细胞类型特异性的方式抑制 EBV 的裂解复制。

Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner.

机构信息

Department of Biology, University of North Carolina at Greensboro, Greensboro, North Carolina 27402, USA.

出版信息

Virol J. 2014 Jun 11;11:110. doi: 10.1186/1743-422X-11-110.

DOI:10.1186/1743-422X-11-110
PMID:24917448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4059732/
Abstract

BACKGROUND

Epstein-Barr virus is a human herpesvirus that infects a majority of the human population. Primary infection of Epstein-Barr virus (EBV) causes the syndrome infectious mononucleosis. This virus is also associated with several cancers, including Burkitt's lymphoma, post-transplant lymphoproliferative disorder and nasopharyngeal carcinoma. As all herpesvirus family members, EBV initially replicates lytically to produce abundant virus particles, then enters a latent state to remain within the host indefinitely.

METHODS

Through a genetic screen in Drosophila, we determined that reduction of Drosophila Tor activity altered EBV immediate-early protein function. To further investigate this finding, we inhibited mTOR in EBV-positive cells and investigated subsequent changes to lytic replication via Western blotting, flow cytometry, and quantitative PCR. The student T-test was used to evaluate significance.

RESULTS

mTOR, the human homolog of Drosophila Tor, is an important protein at the center of a major signaling pathway that controls many aspects of cell biology. As the EBV immediate-early genes are responsible for EBV lytic replication, we examined the effect of inhibition of mTORC1 on EBV lytic replication in human EBV-positive cell lines. We determined that treatment of cells with rapamycin, which is an inhibitor of mTORC1 activity, led to a reduction in the ability of B cell lines to undergo lytic replication. In contrast, EBV-positive epithelial cell lines underwent higher levels of lytic replication when treated with rapamycin.

CONCLUSIONS

Overall, the responses of EBV-positive cell lines vary when treated with mTOR inhibitors, and this may be important when considering such inhibitors as anti-cancer therapeutic agents.

摘要

背景

Epstein-Barr 病毒是一种感染大多数人类的人类疱疹病毒。Epstein-Barr 病毒(EBV)的原发性感染会导致传染性单核细胞增多症综合征。这种病毒还与几种癌症有关,包括 Burkitt 淋巴瘤、移植后淋巴组织增生性疾病和鼻咽癌。与所有疱疹病毒家族成员一样,EBV 最初通过裂解方式复制,产生大量病毒颗粒,然后进入潜伏状态,在宿主体内无限期存在。

方法

通过在果蝇中的基因筛选,我们确定减少果蝇 Tor 活性会改变 EBV 早期蛋白的功能。为了进一步研究这一发现,我们在 EBV 阳性细胞中抑制 mTOR,并通过 Western blot、流式细胞术和定量 PCR 研究随后对裂解复制的变化。学生 t 检验用于评估显著性。

结果

mTOR 是果蝇 Tor 的人类同源物,是控制细胞生物学许多方面的重要信号通路的中心蛋白。由于 EBV 早期基因负责 EBV 的裂解复制,我们研究了抑制 mTORC1 对人 EBV 阳性细胞系中 EBV 裂解复制的影响。我们发现,用 rapamycin(一种 mTORC1 活性抑制剂)处理细胞会导致 B 细胞系裂解复制能力降低。相比之下,当用 rapamycin 处理时,EBV 阳性上皮细胞系会经历更高水平的裂解复制。

结论

总的来说,当用 mTOR 抑制剂处理 EBV 阳性细胞系时,它们的反应不同,这在考虑将此类抑制剂作为抗癌治疗药物时可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/9920bba81282/1743-422X-11-110-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/361cd9e6b173/1743-422X-11-110-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/6af372863b87/1743-422X-11-110-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/9a488c0ddfdc/1743-422X-11-110-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/ca5e9edf0ade/1743-422X-11-110-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/a5aace7afb7f/1743-422X-11-110-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/aed73425a505/1743-422X-11-110-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/db527871ed67/1743-422X-11-110-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/9920bba81282/1743-422X-11-110-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/361cd9e6b173/1743-422X-11-110-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/6af372863b87/1743-422X-11-110-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/9a488c0ddfdc/1743-422X-11-110-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/ca5e9edf0ade/1743-422X-11-110-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/a5aace7afb7f/1743-422X-11-110-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/aed73425a505/1743-422X-11-110-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/db527871ed67/1743-422X-11-110-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79c1/4059732/9920bba81282/1743-422X-11-110-8.jpg

相似文献

1
Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner.mTORC1 的抑制作用以细胞类型特异性的方式抑制 EBV 的裂解复制。
Virol J. 2014 Jun 11;11:110. doi: 10.1186/1743-422X-11-110.
2
PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas.PI3Kδ 抑制增强了雷帕霉素抑制 EBV+B 细胞淋巴瘤增殖的疗效。
Am J Transplant. 2013 Aug;13(8):2035-43. doi: 10.1111/ajt.12328. Epub 2013 Jul 10.
3
Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.氯硝柳胺通过破坏mTOR激活来抑制爱泼斯坦-巴尔病毒的裂解复制。
Antiviral Res. 2017 Feb;138:68-78. doi: 10.1016/j.antiviral.2016.12.002. Epub 2016 Dec 8.
4
Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.细胞分化调节因子BLIMP1通过激活R和Z启动子的转录,诱导上皮细胞和B细胞中的爱泼斯坦-巴尔病毒裂解性再激活。
J Virol. 2015 Feb;89(3):1731-43. doi: 10.1128/JVI.02781-14. Epub 2014 Nov 19.
5
Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.ATM 在鼻咽上皮细胞裂解性复制 EBV 过程中复制隔间形成中的作用。
J Virol. 2015 Jan;89(1):652-68. doi: 10.1128/JVI.01437-14. Epub 2014 Oct 29.
6
A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.一种基于机制的靶向筛选方法,用于鉴定 Epstein-Barr 病毒导向的抗病毒药物。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01179-20.
7
The mTOR inhibitor manassantin B reveals a crucial role of mTORC2 signaling in Epstein-Barr virus reactivation.mTOR 抑制剂 manassantin B 揭示了 mTORC2 信号在 Epstein-Barr 病毒激活中的关键作用。
J Biol Chem. 2020 May 22;295(21):7431-7441. doi: 10.1074/jbc.RA120.012645. Epub 2020 Apr 20.
8
hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.端粒酶逆转录酶抑制触发永生和转化 B 细胞中的 Epstein-Barr 病毒裂解周期和细胞凋亡:新疗法的基础。
Clin Cancer Res. 2013 Apr 15;19(8):2036-47. doi: 10.1158/1078-0432.CCR-12-2537. Epub 2013 Feb 26.
9
BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.爱泼斯坦-巴尔病毒阳性上皮细胞系中的BZLF1转录变体
Virus Genes. 2019 Dec;55(6):779-785. doi: 10.1007/s11262-019-01705-8. Epub 2019 Sep 24.
10
Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白1通过mTORC1/核因子-κB信号通路上调葡萄糖转运蛋白1的转录
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.02168-16. Print 2017 Mar 15.

引用本文的文献

1
Novel Role of the Epstein-Barr Virus Encoded Deubiquitinating Enzyme (BPLF1) in mTOR-Mediated Cell Growth and Proliferation Pathways.爱泼斯坦-巴尔病毒编码的去泛素化酶(BPLF1)在mTOR介导的细胞生长和增殖途径中的新作用。
Viruses. 2025 Aug 20;17(8):1139. doi: 10.3390/v17081139.
2
Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome.组蛋白变体H2A.Z与EBNA1协同作用以维持爱泼斯坦-巴尔病毒潜伏表观基因组。
mBio. 2025 Jul 14:e0030225. doi: 10.1128/mbio.00302-25.
3
Metformin in Antiviral Therapy: Evidence and Perspectives.

本文引用的文献

1
Regulation of mTORC1 and its impact on gene expression at a glance.mTORC1 的调控及其对基因表达的影响一览
J Cell Sci. 2013 Apr 15;126(Pt 8):1713-9. doi: 10.1242/jcs.125773. Epub 2013 May 2.
2
A study of Epstein-Barr virus BRLF1 activity in a Drosophila model system.在果蝇模型系统中对爱泼斯坦-巴尔病毒BRLF1活性的一项研究。
ScientificWorldJournal. 2012;2012:347597. doi: 10.1100/2012/347597. Epub 2012 Apr 26.
3
mTOR Signaling.mTOR 信号通路
二甲双胍在抗病毒治疗中的应用:证据与展望
Viruses. 2024 Dec 18;16(12):1938. doi: 10.3390/v16121938.
4
Post-transplant lymphoproliferative disease after pediatric kidney transplant.小儿肾移植后移植后淋巴细胞增生性疾病
Front Pediatr. 2022 Dec 7;10:1087864. doi: 10.3389/fped.2022.1087864. eCollection 2022.
5
An Update on the Metabolic Landscape of Oncogenic Viruses.致癌病毒代谢格局的最新进展。
Cancers (Basel). 2022 Nov 23;14(23):5742. doi: 10.3390/cancers14235742.
6
EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis.EBV 感染及其在鼻咽癌发生中的代谢重编程调控。
Front Cell Infect Microbiol. 2022 Jul 1;12:935205. doi: 10.3389/fcimb.2022.935205. eCollection 2022.
7
mTORC2 confers neuroprotection and potentiates immunity during virus infection.mTORC2 在病毒感染期间赋予神经保护和增强免疫作用。
Nat Commun. 2021 Oct 14;12(1):6020. doi: 10.1038/s41467-021-26260-5.
8
Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways.白藜芦醇、雷帕霉素和二甲双胍作为抗病毒途径的调节剂。
Viruses. 2020 Dec 17;12(12):1458. doi: 10.3390/v12121458.
9
Lytic Induction Therapy against Epstein-Barr Virus-Associated Malignancies: Past, Present, and Future.针对爱泼斯坦-巴尔病毒相关恶性肿瘤的溶瘤诱导疗法:过去、现在与未来
Cancers (Basel). 2020 Aug 2;12(8):2142. doi: 10.3390/cancers12082142.
10
The mTOR inhibitor manassantin B reveals a crucial role of mTORC2 signaling in Epstein-Barr virus reactivation.mTOR 抑制剂 manassantin B 揭示了 mTORC2 信号在 Epstein-Barr 病毒激活中的关键作用。
J Biol Chem. 2020 May 22;295(21):7431-7441. doi: 10.1074/jbc.RA120.012645. Epub 2020 Apr 20.
Cold Spring Harb Perspect Biol. 2012 Feb 1;4(2):a011593. doi: 10.1101/cshperspect.a011593.
4
Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.雷帕霉素逆转了 Epstein-Barr 病毒相关伯基特淋巴瘤转基因模型的脾肿大并抑制肿瘤发展。
Mol Cancer Ther. 2011 Apr;10(4):679-86. doi: 10.1158/1535-7163.MCT-10-0833. Epub 2011 Jan 31.
5
Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.雷帕霉素阻断 KSHV/HHV8 的产生:免疫抑制剂药物抗肿瘤活性的新见解。
PLoS One. 2011 Jan 14;6(1):e14535. doi: 10.1371/journal.pone.0014535.
6
The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis.人乳头瘤病毒 16 型 E6 癌蛋白激活 mTORC1 信号通路并增加蛋白质合成。
J Virol. 2010 Sep;84(18):9398-407. doi: 10.1128/JVI.00974-10. Epub 2010 Jul 14.
7
Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.雷帕霉素耐药的 mTORC1 激酶活性是疱疹病毒复制所必需的。
J Virol. 2010 May;84(10):5260-9. doi: 10.1128/JVI.02733-09. Epub 2010 Feb 24.
8
mTOR signaling at a glance.mTOR信号通路概述。
J Cell Sci. 2009 Oct 15;122(Pt 20):3589-94. doi: 10.1242/jcs.051011.
9
Rapamycin inhibits mTORC1, but not completely.雷帕霉素可抑制mTORC1,但不能完全抑制。
Autophagy. 2009 Jul;5(5):725-6. doi: 10.4161/auto.5.5.8504. Epub 2009 Jul 22.
10
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.一种ATP竞争性的雷帕霉素哺乳动物靶点抑制剂揭示了mTORC1的雷帕霉素抗性功能。
J Biol Chem. 2009 Mar 20;284(12):8023-32. doi: 10.1074/jbc.M900301200. Epub 2009 Jan 15.